DOSSIER · 13F Holders · Q2 2026Healthcare · In Vitro & In Vivo Diagnostic Substances
NEOG
NEOGEN CORP
335 institutions still hold NEOGEN CORP as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 640491106·In Vitro & In Vivo Diagnostic Substances·335 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
335 institutions reported NEOG in Q2 2026. BlackRock, Inc. leads at 19.7% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 17
315 more holders available. Log in →